Cells is under clinical development by ICamuno Biotherapeutics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I drugs for Ovarian Cancer have a 73% phase transition ...

Eterna Therapeutics, Inc. (ERNA) announced Tuesday positive results from a preclinical study on the company's lead cell therapy ...

A new international study shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. A new international study led by researchers at Karolinska ...

Retraction Note: Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis. Retraction Note: Hsa_circ_0001944 ...

When the labeled antibody was released near ovarian cancer cells, its Y-shaped arms bound to the cells. The researchers then fused the labeled arms to the stem of a human antibody, generating a ...

By successfully turning the “cold” tumor into “hot” – transforming the tumor microenvironment from having low immune activity to an active immune environment – ERNA-101 may not only lead to improved ...

ERNA-101 is a cell therapy that utilizes induced pluripotent stem cells (iPSCs ... University of Texas MD Anderson Cancer Center, researchers developed an ovarian tumor model by injecting ID8 ...